In a June 18 report, analyst Gianluca Tucci reiterated his “Buy” rating and raised his target price to C$4.20 from C$3.75.

Kye Pharmaceuticals, Inc. (“Kye”) today announced that Health Canada has approved its SNDS (Supplemental New Drug Submission) ...

Cost of gas rate remains steady for another quarter SURREY, BC, June 18, 2025 /CNW/ – FortisBC Energy Inc. (FortisBC) has ...

The summer tourism season is here, and 58% of small business owners are concerned the U.S.-Canada trade dispute will be ...

The governments of Canada and Quebec, the Municipality of Nominingue and the Association Développement Nominingue (ADN) today ...

BRP Inc. (TSX: DOO) (NASDAQ: DOOO) is excited to announce today the opening of its first European flagship store in ...

From history to hope: 2 cottages, 20 units, and 1 powerful step toward ending homelessness for women in Calgary. The ...

As companies strive to stay nimble and deliver on critical business initiatives, new research from talent solutions and ...

Desilva expects USA Rare Earth to post an Adjusted EBITDA loss of $0.60-million on no revenue in fiscal 2025. He forecasts ...

Novartis Canada is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for KISQALI® (ribociclib ...

La Caisse announces the creation of the Prix La Caisse en art actuel to support mid-career artists in Québec. This $25,000 ...

Empowering Canadian innovation—discover, invest, and grow with homegrown tech leaders shaping the future. The 2025 Cantech ...